Chan Wen-Hui, Hung Chien-Fu, Pan Kuang-Tse, Lui Kar-Wai, Huang Yu-Ting, Lin Shen-Yen, Lin Yang-Yu, Wu Tsung-Han, Yu Ming-Chin
Department of Medical Imaging and Intervention, Chang Gung Memorial Hospital, Linkou, Chang Gung University, Taoyuan, Taiwan.
Division of General Surgery, Department of Surgery, Chang Gung Memorial Hospital, Linkou, Chang Gung University, Taoyuan, Taiwan.
J Surg Oncol. 2016 Jun;113(7):789-95. doi: 10.1002/jso.24245. Epub 2016 Apr 7.
Compare the outcomes of three groups of patients with T4 hepatocellular carcinoma (HCC): tumor rupture with shock (RS group), tumor rupture without shock (R group), and no tumor rupture (NR group).
We retrospectively reviewed 221 patients with T4 HCC from 2010 to 2012. The clinical background and prognosis were analyzed.
Overall in-hospital mortality rate was 18.1%; overall median survival time was 4 months. The NR group were more likely to have multiple and infiltrative tumors (P < 0.001). Relative to the NR group, the R + RS group had better survival rates at 6 months (49.2% vs. 32.2%), 1 year (35.3% vs. 21.0%), 3 years (22.5% vs. 11.0%), and 5 years (17.7% vs. 5.5%) (P = 0.010). Patients in the RS group had a higher in-hospital mortality rate, but significantly better long-term survival than the NR and R group (P < 0.001). Multivariate analysis indicated that Child-Pugh class B or C, presence of portal venous thrombosis, and absence of shock were significantly associated with poor survival.
Patients with tumor rupture and shock had worse in-hospital survival. However, patients without decompensated liver cirrhosis and portal venous thrombosis, and eligible for curative treatment had favorable long-term outcome. J. Surg. Oncol. 2016;113:789-795. © 2016 The Authors. Journal of Surgical Oncology Published by Wiley Periodicals, Inc.
比较三组T4期肝细胞癌(HCC)患者的预后情况:肿瘤破裂伴休克组(RS组)、肿瘤破裂不伴休克组(R组)和无肿瘤破裂组(NR组)。
我们回顾性分析了2010年至2012年间221例T4期HCC患者的临床资料,并对其临床背景及预后进行分析。
总体院内死亡率为18.1%;总体中位生存时间为4个月。NR组更易出现多发及浸润性肿瘤(P<0.001)。与NR组相比,R + RS组在6个月(49.2%对32.2%)、1年(35.3%对21.0%)、3年(22.5%对11.0%)和5年(17.7%对5.5%)时的生存率更高(P = 0.010)。RS组患者的院内死亡率较高,但长期生存率显著优于NR组和R组(P<0.001)。多因素分析表明,Child-Pugh B级或C级、门静脉血栓形成以及无休克与生存不良显著相关。
肿瘤破裂伴休克的患者院内生存情况较差。然而,无失代偿期肝硬化和门静脉血栓形成且适合进行根治性治疗的患者长期预后良好。《外科肿瘤学杂志》2016年;113:789 - 795。© 2016作者。《外科肿瘤学杂志》由威利期刊公司出版。